1
|
Salachas C, Le Hingrat Q, Haviari S, Valdes A, Mackiewicz V, Lolom I, Fidouh N, Visseaux B, Bouzid D, Descamps D, Lucet JC, Charpentier C, Kernéis S. Associations between hospital structure, infection control and incidence of hospital-acquired viral respiratory infections: a 10-year surveillance study. Antimicrob Resist Infect Control 2025; 14:28. [PMID: 40217353 PMCID: PMC11992881 DOI: 10.1186/s13756-025-01543-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2024] [Accepted: 03/22/2025] [Indexed: 04/14/2025] Open
Abstract
BACKGROUND Protecting patients from hospital-acquired viral respiratory infections is a major challenge, but the hierarchy of measures to achieve this is not yet completely clear. AIM To describe the epidemiology of hospital-acquired viral respiratory infections and associations with structural hospital factors and adherence to infection control protocols. METHODS Retrospective cohort study conducted over 10 consecutive years (2014-2023) within 27 hospital wards in a 900-bed university hospital in Paris, France. All hospitalized adult patients who were tested for at least one virus on a respiratory sample during their stay were included. Structural factors (percentage of double occupancy rooms) and adherence to infection control protocols by healthcare workers (measured by consumption of alcohol-based hand sanitizer and of facemasks) were included as predictors in the model. MAIN OUTCOME AND MEASURE Incidence of hospital-acquired viral respiratory infections, defined by a positive PCR test for at least one respiratory virus, performed at least 5 days after hospital admission. Data were analyzed on ward-year aggregated data, with a linear mixed-effects model. FINDINGS Overall, 183 994 viral PCR tests were performed over the study period. Incidence of hospital-acquired viral respiratory infections was 0.57/1000 hospital-days. After adjustment on other factors (mean length of stay, use of PCR testing), incidence of hospital-acquired viral respiratory infections in a given ward was significantly associated with: the incidence of community-acquired viral respiratory infections among patients admitted to the ward (+ 0.10/1000 hospital-days per each additional point of incidence; P < 0.001), the number of double-occupancy rooms (+ 0.04/1000 hospital-days per each 10%-increase of double-occupancy rooms; P = 0.03) and masks consumption (+ 0.33/1000 hospital-days per 10 additional masks used per day; P = 0.04). Similar results were found for double-occupancy rooms (+ 0.01/1000 hospital-days per each 10%-increase of double-occupancy rooms; P = 0.012) in the sub-group analysis of influenza cases. CONCLUSION In a given hospital ward, the incidence of community-acquired cases and the proportion of double-occupancy rooms are independently associated with the incidence hospital-acquired viral respiratory infections.
Collapse
Affiliation(s)
- Costa Salachas
- Université Paris Cité, INSERM, IAME, F-75018, Paris, France
- Équipe de Prévention du Risque Infectieux (EPRI), AP-HP, Hôpital Bichat, 75018, Paris, France
| | - Quentin Le Hingrat
- Université Paris Cité, INSERM, IAME, F-75018, Paris, France
- Laboratoire de virologie, APHP, Hôpital Bichat, 75018, Paris, France
| | - Skerdi Haviari
- Université Paris Cité, INSERM, IAME, F-75018, Paris, France
- Département Épidémiologie Biostatistiques Et Recherche Clinique, AP-HP, Hôpital Bichat, 75018, Paris, France
| | - Audrey Valdes
- Infection Control Unit, Centre Hospitalier de Vichy, Vichy, France
| | | | - Isabelle Lolom
- Équipe de Prévention du Risque Infectieux (EPRI), AP-HP, Hôpital Bichat, 75018, Paris, France
| | - Nadhira Fidouh
- Laboratoire de virologie, APHP, Hôpital Bichat, 75018, Paris, France
| | - Benoît Visseaux
- Université Paris Cité, INSERM, IAME, F-75018, Paris, France
- Laboratoire de virologie, APHP, Hôpital Bichat, 75018, Paris, France
| | - Donia Bouzid
- Université Paris Cité, INSERM, IAME, F-75018, Paris, France
- Service d'Accueil des Urgences, AP-HP, Hôpital Bichat, 75018, Paris, France
| | - Diane Descamps
- Université Paris Cité, INSERM, IAME, F-75018, Paris, France
- Laboratoire de virologie, APHP, Hôpital Bichat, 75018, Paris, France
| | - Jean-Christophe Lucet
- Université Paris Cité, INSERM, IAME, F-75018, Paris, France
- Équipe de Prévention du Risque Infectieux (EPRI), AP-HP, Hôpital Bichat, 75018, Paris, France
| | - Charlotte Charpentier
- Université Paris Cité, INSERM, IAME, F-75018, Paris, France
- Laboratoire de virologie, APHP, Hôpital Bichat, 75018, Paris, France
| | - Solen Kernéis
- Université Paris Cité, INSERM, IAME, F-75018, Paris, France.
- Équipe de Prévention du Risque Infectieux (EPRI), AP-HP, Hôpital Bichat, 75018, Paris, France.
| |
Collapse
|
2
|
Most ZM, Perl TM, Sebert M. Respiratory virus infections in symptomatic and asymptomatic children upon hospital admission: new insights. ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY : ASHE 2024; 4:e162. [PMID: 39411664 PMCID: PMC11474761 DOI: 10.1017/ash.2024.407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/06/2024] [Accepted: 07/22/2024] [Indexed: 10/19/2024]
Abstract
Objective Describe and compare the prevalence of symptomatic and asymptomatic or recently resolved respiratory infections in hospitalized children. Design Cross-sectional study. Setting Three hospital primary-to-quaternary care pediatric healthcare system. Patients People less than 22 years old who underwent admission screening for respiratory viruses using a multitarget polymerase chain reaction (PCR) panel from August 2020 through April 2022. Methods The symptom status of each patient was recorded by the ordering provider. The prevalence of each virus was described comparing symptomatic and asymptomatic patients. Results for each virus were stratified by age group and trends were examined over time. Results Of the 32,812 eligible PCR panels collected, 12,965 (39.5%), 18,651 (56.8%), and 1,196 (3.6%) were obtained from patients who were symptomatic, asymptomatic, or had missing or unknown symptom status, respectively. Symptomatic patients were much more likely to test positive for a respiratory virus (67.3% vs 27.0%). The most common viruses detected in asymptomatic patients were rhinovirus/enterovirus (18.0%), SARS-CoV-2 (3.6%), and parainfluenza viruses (2.3%). The odds ratio of testing positive when symptomatic was significantly greater than unity for all viruses but varied by virus and age group. The proportion of positive tests for each virus was dynamic and changed with intermittent epidemics, or viral "waves." Conclusions More than one-quarter of children without respiratory symptoms admitted to a pediatric healthcare system had PCR-detectable respiratory viruses. Children with symptoms of a respiratory infection are nevertheless much more likely to have a respiratory virus detected by PCR.
Collapse
Affiliation(s)
- Zachary M. Most
- Division of Infectious Disease, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA
- Children’s Health System of Texas, Dallas, TX, USA
- Peter O’Donnell, Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - Trish M. Perl
- Division of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA
- Peter O’Donnell, Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - Michael Sebert
- Division of Infectious Disease, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA
- Children’s Health System of Texas, Dallas, TX, USA
| |
Collapse
|
3
|
Petrie JG, Moore R, Lauring AS, Kaye KS. Incidence and outcomes of hospital-associated respiratory virus infections by viral species. Infect Control Hosp Epidemiol 2024; 45:618-629. [PMID: 38073596 PMCID: PMC11031349 DOI: 10.1017/ice.2023.263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/19/2024]
Abstract
BACKGROUND Although the incidence of hospital-associated respiratory virus infection (HARVI) is well recognized, the risk factors for infection and impact on patient outcomes are not well characterized. METHODS We identified a cohort of all inpatient admissions ≥24 hours duration at a single academic medical center from 2017 to 2020. HARVI were defined as respiratory virus detected in a test ordered after the 95th percentile of the virus-specific incubation period. Risk factors for HARVI were assessed using Cox proportional hazards models of the competing outcomes of HARVI and discharge. The associations between time-varying HARVI status and the rates of ICU admission, discharge, and in-hospital death were estimated using Cox-proportional hazards models in a competing risk framework. RESULTS HARVI incidences were 8.8 and 3.0 per 10,000 admission days for pediatric and adult patients, respectively. For adults, congestive heart failure, renal disease, and cancer increased HARVI risk independent of their associations with length of stay. HARVI risk was also elevated for patients admitted in September-June relative to July admissions. For pediatric patients, cardiovascular and respiratory conditions, cancer, medical device dependence, and admission in December increased HARVI risk. Lengths of stay were longer for adults with HARVI compared to those without, and hospital-associated influenza A was associated with increased risk of death. Rates of ICU admission were increased in the 5 days after HARVI identification for adult and pediatric patients. HARVI was not associated with length of stay or death among pediatric patients. CONCLUSIONS HARVI is associated chronic health conditions and increases morbidity and mortality.
Collapse
Affiliation(s)
- Joshua G. Petrie
- Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin
| | - Riley Moore
- Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan
| | - Adam S. Lauring
- Department of Microbiology and Immunology and Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
| | - Keith S. Kaye
- Division of Allergy, Immunology and Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson School of Medicine, New Brunswick, New Jersey
| |
Collapse
|